Medorekkusu
4586.TTSE GROWTHPharmaceutical
Filed as Medrx Co.,Ltd. (2022-08–2026-08)
Major holders (5%+) · 2
| Holder | Stake |
|---|---|
| Matsumura Yonehiro | 10.57% |
| Growth Capital Inc. | 6.15% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 3
| Long Corridor Asset Management Limited | 4.78% |
| Evo Fund | 4.22% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 59
| Holder | Ratio | Change |
|---|---|---|
| Evo Fund2024-02-13 · amended | 9.46% | -1.73pp |
| Evolution Capital Management LLC2024-02-13 · amended | 0.00% | no change |
| Evo Fund2024-02-13 · amended | 11.19% | -1.06pp |
| Evolution Capital Management LLC2024-02-13 · amended | 0.00% | no change |
| Evo Fund2024-02-13 · amended | 12.25% | -1.34pp |
| Evolution Capital Management LLC2024-02-13 · amended | 0.00% | no change |
| Evo Fund2024-02-13 · amended | 13.59% | -1.14pp |
| Evolution Capital Management LLC2024-02-13 · amended | 0.00% | no change |
| Evo Fund2024-02-13 · amended | 14.73% | -1.13pp |
| Evolution Capital Management LLC2024-02-13 · amended | 0.00% | no change |
| Evo Fund2024-02-13 · amended | 15.86% | -1.07pp |
| Evolution Capital Management LLC2024-02-13 · amended | 0.00% | no change |
| Evo Fund2024-02-13 · amended | 16.93% | -1.35pp |
| Evolution Capital Management LLC2024-02-13 · amended | 0.00% | no change |
| Evo Fund2024-02-13 · amended | 18.28% | -1.15pp |
| Evolution Capital Management LLC2024-02-13 · amended | 0.00% | no change |
| Evo Fund2024-02-13 · amended | 19.43% | +0.12pp |
| Evolution Capital Management LLC2024-02-13 · amended | 0.00% | new |
| Evo Fund2024-02-13 · amended | 19.31% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.